 | Articles: General Pharma
|
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
Corporate News Releases, 05/12/08
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
Corporate News Releases, 05/12/08
Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
Corporate News Releases, 05/12/08
Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
Corporate News Releases, 05/12/08
Neuralstem Sues StemCells, Inc. Over New Patent
Corporate News Releases, 05/12/08
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Corporate News Releases, 05/12/08
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
Corporate News Releases, 05/12/08
Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
Corporate News Releases, 05/12/08
Orexigen(R) Therapeutics Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave(R)
Corporate News Releases, 05/12/08
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Corporate News Releases, 05/12/08
|
 Receive daily email updates on General Pharma
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
